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Abstract: Tako-Tsubo cardiomyopathy (TTC) is an acute reversible cause of segmental myocardial dysfunction that is poorly   understood 
and cannot be explained by the occlusion of a single coronary vessel. Its clinical presentation is similar to that of acute coronary 
  syndrome and is often precipitated by a severe psychological or physical stress.
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Tamoxifen, a selective estrogen receptor   modulator 
(SERM)  is  also  a  partial  estrogen  agonist  and  is 
  associated  with  an  increased  incidence  of  both 
  thromboembolic  events  and  an  enhanced  level  of 
serum triglyceride, although the relevance of this with 
respect to cardiovascular risk remains uncertain.
A 92-year-old woman was admitted to the inten-
sive care unit with acute onset of pain in the back with 
radiation to the left shoulder, as well as mild respi-
ratory distress. She had a medical history of similar 
episodes of chest pain not however investigated with 
non-invasive or invasive methods of ischemic diag-
nostic, along with hypertension for about 35 years, 
and paroxysmal atrial fibrillation. She had no history 
of any recent major emotional or physical stress. The 
patient was taking an angiotensin converting enzyme 
inhibitor,  β-Blocker, Tamoxifen  (for  three  months) 
and  Coumadin.  On  admission,  her  blood  pressure 
was 199/119 mmHg and radial pulse rate 90 bpm. 
  Cardiovascular  examination  revealed  soft  heart 
sounds, no gallop rhythm, and an early systolic mur-
mur was heard in the apical region.   Echocardiography 
showed  mild  mitral  regurgitation  and  wall  motion 
abnormalities including apical dyskinesia, as well as 
mild hypokinesia in mid-segments of the anterior and 
lateral walls. Bilateral lung crepitating were heard at 
auscultation, and chest radiography revealed pulmo-
nary oedema. The initial 12-lead electrocardiogram 
showed atrial fibrillation with significant ST depres-
sion in leads I, aVL and V4–6, and inverted T-waves in 
leads II, III, V3–6 associated with undervolted QRS, 
with no R wave progress from V1 to V3 and lengthen-
ing of QT interval. Blood tests performed concomi-
tantly revealed severe elevation of cardiac troponin 
(39.16 ug/L) and creatinine kinase levels 550 U/L 
(normal range: 12–140 U/L).
Emergency coronary angiography showed normal 
coronary arteries with no luminal narrowings (data not 
shown); however, left ventriculography revealed an 
apical sparing with preserved basal and midventricu-
lar contractile function and ejection fraction of the left 
ventricle of 45% (movie). Echocardiography (data not 
shown) repeated 6 weeks after the index event showed 
a left ventricular ejection fraction of 64% with com-
plete resolution of wall motion abnormalities in api-
cal segments. Therefore, our patient was diagnosed 
with a variant of Tako-Tsubo cardiomyopathy (TTC), 
where a small area at the apex is spared (movie).1 
TTC is mainly seen in   post-  menopausal women aged 
between 50 and 80 years of age precipitate, without 
risk factors for coronary artery disease.2
We present a rare clinical case in which transient 
apical  sparing  was  encountered  in  a  very  elderly 
woman  (92-year  old)  without  psychological  stress 
or an acute episode of major depression.3 The patient 
was started on 30 mg Tamoxifen daily as sole treat-
ment  for  breast  cancer  three  months  ago  and  she 
did not undergo any kind of operation for the breast 
cancer previously. Tamoxifen is a selective estrogen 
receptor modulator with both estrogen agonistic and 
antagonistic properties, and it is the most widely pre-
scribed therapy for breast cancer reduction. Tamox-
ifen binds to estrogen receptors (ER) and prevents 
the binding of endogenous and exogenous estrogen. 
During Tamoxifen therapy in elderly postmenopausal 
women low concentrations of the patient’s own estro-
gen could not directly act on the estrogen receptors in 
the heart and could not have a protective effect.
Tako-Tsubo left ventricular dysfunction has been 
described  by  reduction  of  estrogen  levels  in  ova-
riectomized  female  rats  and  an  incidence  of TTC 
in elderly postmenopausal females suggesting that 
a reduction of estrogen levels may be involved in 
this myocardial disease.4 The estrogen breast can-
cer treatment may modulate the estrogen levels in 
postmenopausal women and thus be involved in the 
pathophysiology  of  transient  left  ventricular  dys-
function syndrome. Some authors have recently also 
suggested that the desensitizing effect of estrogen 
on cardiac response to catecholamines may create a 
rebound hypersensitivity after menopause and thus 
a putative mechanism for the clustering of cases in 
postmenopausal   women.5 In addition, the vascular 
and cardiac response to endogenous and exogenous 
estrogens appears to change with aging. The estro-
gen could prevent the development of cardiac vas-
cular disease in newly menopausal women it would 
have no or even harmful effects in older postmeno-
pausal women with established risk of cardiovascu-
lar disease. This has been referred to as the “timing 
hypothesis”.6 The mechanism underlying the asso-
ciation between estrogen level and TTC is unknown 
and further clinical work is necessary to understand 
this phenomenon.
Our patient had also a history of malignancy at the 
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A recent study has reported a high prevalence of 
cancer in patients with Tako-Tsubo cardiomyopathy, 
but  the  pathophysiological  mechanisms  of  action 
remain unclear.7 It has to be questioned whether the 
malignancies  and/or  chemotherapy  pronounce  the 
cardiac toxicity and potential cardiac problems.
The cardiomyopathy observed in this very elderly 
woman represents an unusual and rare case of api-
cal  sparing  variant  of Tako-Tsubo  disease  induced 
without emotional stress, but after receiving selec-
tive estrogen receptor modulator. The role of estro-
gen and/or malignancy in the genesis of Tako-Tsubo 
  syndrome is still unclear and further additional analy-
ses with regard to the their effects on the incidence of 
TTC should be performed.
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